Trial Identifier: | D8850R00002 |
Sponsor: | AstraZeneca |
Collaborator: |
Clalit Health Services
|
NCTID:: | NCT05712096 |
Start Date: | March 2023 |
Primary Completion Date: | May 2023 |
Study Completion Date: | May 2023 |
Condition: | COVID-19 Immunisation |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Israel | Ramat Gan, Israel |